Manufacturer record

Shine Pharmaceuticals Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

9 batches manufactured by Shine Pharmaceuticals Limited (Gujarat) were declared Not of Standard Quality between December 2020 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

9 records linked to Shine Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
9Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2020 to Jun 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

9
NSQ batches since 2020
6
Products affected
Related substances
Most common failure
Jun 2025
Latest alert

Flagged batches per year

2020 · 12021 · 12022 · 12023 · 32024 · 12025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Lorazepam Tablets IP 2 mg (Proline-2) 05P23T03Mfg 2023-03 · Exp 2027-02 Assay for LorazepamAssay State Lab KarnatakaState lab Jun 2025
Lorazepam Tablets IP 1 mg (PROLINE - 1) 06P23T03Mfg 2023-08 · Exp 2027-04 AssayAssay CDTL MumbaiCDSCO lab Jan 2025
Clonazepam TabletsI.P.0.5mg 04L23T0 3Mfg 2023-12 · Exp 2026-11 The sample does not conforms to claim as per IP in respect to The Test of Related SubstancesRelated substances CDL KolkataCDSCO lab May 2024
Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) 43L22T01Mfg 2022-03 · Exp 2025-02 Related SubstancesRelated substances CDL KolkataCDSCO lab Jul 2023
Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) 43L23T01Mfg 2023-02 · Exp 2026-01 Related SubstancesRelated substances CDL KolkataCDSCO lab Jul 2023
Lonapam� MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) 43L22T03Mfg 2022-09 · Exp 2025-08 Related SubstancesRelated substances CDL KolkataCDSCO lab Jul 2023
Atorvastatin Calcium Tablets I.P. 40 mg 17T20T07Mfg 2020-10 · Exp 2023-09 DissolutionDissolution CDL KolkataCDSCO lab Jun 2022
TLM-80 (Telmisartan Tablets I.P. 80 mg) 31T20T02Mfg 2020-08 · Exp 2022-07 DissolutionDissolution CDL KolkataCDSCO lab Apr 2021
Alora 0.25 (Alprazolam Tablets I.P. 0.25 mg) 03A19T02Mfg 2019-11 · Exp 2022-10 DissolutionDissolution CDL KolkataCDSCO lab Dec 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.